IVERIC bio, Inc.

Avoro Capital Advisors LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

8,050,000

Value ($000)

316,687

Weight

4.3%

2020 Q2 - 2023 Q2 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	316,687	4.3%	8,050,000	6/30/2023
2023 Q1	5/15/2023	165,444	2.5%	6,800,000	3/31/2023
2022 Q4	2/14/2023	144,518	2.2%	6,750,000	12/31/2022
2022 Q3	11/14/2022	105,846	2.0%	5,900,000	9/30/2022
2022 Q2	8/15/2022	68,494	1.4%	7,120,000	6/30/2022
2022 Q1	5/16/2022	122,018	2.2%	7,250,000	3/31/2022
2021 Q4	2/14/2022	121,220	2.1%	7,250,000	12/31/2021
2021 Q3	11/15/2021	115,304	1.8%	7,100,000	9/30/2021
2021 Q2	8/16/2021	40,542	0.7%	6,425,000	6/30/2021
2021 Q1	5/17/2021	44,805	0.8%	7,250,000	3/31/2021
2020 Q4	2/16/2021	50,098	0.9%	7,250,000	12/31/2020
2020 Q3	11/16/2020	40,890	0.6%	7,250,000	9/30/2020
2020 Q2	8/14/2020	36,210	0.7%	7,100,000	6/30/2020